In July 2022 the India National Anti-Doping Agency (INADA) reported an anti-doping rule violation against the Parathlete Aneesh Kumar Surendran Pillai after his sample tested positive for the prohibited substance Hydrochlorothiazide.
Following notification the Parathlete filed a statement in his defence and he was heard for the Anti-Doping Disciplinary Panel of India (ADDPI).
The Parathlete admitted the violation and denied the intentional use of the substance. He explained with evidence that he underwent treatment for his high blood pressure and other conditions and that he had used prescribed medication.
He asserted that he was unaware that the prescribed medication was prohibited. He had informed his doctor that he was an international athlete and he had mentioned his medication on the Doping Control Form.
The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that he committed an anti-doping rule violation. The Panel accepts that the violation was not intentional and that he acted with No Significant Fault or Negligence regarding the prescribed medication.
Therefore the Panel decides on 04 July 2023 to impose a 1 year period of inelgibility on the Athlete, starting on the date of the decision.
